Cure Logo

January 30, 2023

Entrepreneurship

How to Build a Company and Tackle the Toughest Diseases

View all topics

Introduction

Pioneering entrepreneur, investor, and former Genzyme executive Jim Geraghty, JD, MS, shares his extensive and ground-breaking experiences building and fostering biotech companies large and small—and how they overcame the many hurdles faced in developing treatments for rare and serious diseases. Geraghty also talks about his new book, Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology (Cold Spring Laboratory Press), which Nature called “[An] informative, sometimes passionate account [that] mixes patients' struggles with business, medicine, politics and technology." 

Speakers

More about this topic

Starting a Revolution in Treating Rare Diseases

Developing therapies for patients with rare diseases: a career in the Orphan Drug Revolution by Jim Geraghty, JD, MS.

ArticleOct 12, 2023